Literature DB >> 9884679

The new antidepressants. Selective serotonin reuptake inhibitors.

M J Labellarte1, J T Walkup, M A Riddle.   

Abstract

This article provides a resource for choosing among available SSRIs to treat pediatric patients. SSRIs are addressed according to five areas of interest: treatment efficacy data, untoward effects profile, pharmacokinetic characteristics, potential drug-drug interactions, and cost. Strategies for SSRI dosing and pretreatment work-up are also discussed. Included in the article is a reference table for SSRI dosing, available preparations, and cost per dose. Also included is an abbreviated reference table of important cytochrome P-450 isoenzymes, isoenzyme inhibition by SSRIs, and selected psychotropic and somatic medication substrates.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9884679     DOI: 10.1016/s0031-3955(05)70066-3

Source DB:  PubMed          Journal:  Pediatr Clin North Am        ISSN: 0031-3955            Impact factor:   3.278


  5 in total

1.  Depression in Individuals with Epilepsy.

Authors: 
Journal:  Curr Treat Options Neurol       Date:  2000-11       Impact factor: 3.598

2.  The Effect of Sertraline on the Quality of Life for Children and Adolescents with Anxiety Disorder.

Authors:  Nursu Çakin Memik; Işık Karakaya; Özlem Yildiz; Şahika Şişmanlar; Çiğdem Çağlayan; Belma Ağaoğlu
Journal:  Noro Psikiyatr Ars       Date:  2014-03-01       Impact factor: 1.339

Review 3.  Selective serotonin re-uptake inhibitors for children and adolescents.

Authors:  C F Ziervogel
Journal:  Eur Child Adolesc Psychiatry       Date:  2000       Impact factor: 4.785

Review 4.  Pharmacokinetic and pharmacodynamic drug interactions in the treatment of attention-deficit hyperactivity disorder.

Authors:  J S Markowitz; K S Patrick
Journal:  Clin Pharmacokinet       Date:  2001       Impact factor: 6.447

Review 5.  Social anxiety disorder in children and adolescents: epidemiology, diagnosis, and treatment.

Authors:  Sarosh Khalid-Khan; Maria-Paz Santibanez; Carolyn McMicken; Moira A Rynn
Journal:  Paediatr Drugs       Date:  2007       Impact factor: 3.022

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.